他汀二级预防对养老院居民功能与结局的影响
该回顾性队列研究纳入5440名65岁以上、急性心梗后返回养老院的美国居民,通过倾向评分匹配比较新起始他汀者与非使用者。他汀使用与1年死亡率降低相关(HR 0.80,95%CI 0.73-0.87),平均延长生存15.9天(95%CI 9.9-22.0),再住院与功能下降无总体差异。
要点
- 他汀与1年死亡率降低20%相关(HR 0.80,95%CI 0.73-0.87)。
- 平均延长生存15.9天(95%CI 9.9-22.0),功能下降无差异。
- 再住院风险无总体差异(HR 1.06,95%CI 0.98-1.14)。
核心结论
- 在急性心梗后返回养老院的老年居民中,他汀使用可能降低1年死亡率约20%,且不改善功能。
- 临床共同决策时应告知患者或代理人他汀平均获益为1年内延长生存约16天。
研究设计与样本
- 回顾性队列研究,使用2007-2010年美国全国链接数据(MDS评估、医保索赔、在线调查认证与报告系统记录)。
- 纳入65岁及以上、心梗住院后返回养老院、既往未使用他汀的居民,新使用者与非使用者按1:1倾向评分匹配(校正92项特征),匹配后队列5440人,平均年龄83岁,69%为女性。
主要发现
- 他汀使用与死亡率降低相关(HR 0.80,95%CI 0.73-0.87),对应平均延长预期寿命15.9天(95%CI 9.9-22.0)。
- 再住院无总体差异(HR 1.06,95%CI 0.98-1.14)。
- 功能下降无总体差异(HR 1.00,95%CI 0.88-1.14)。
临床怎么用
- 与希望延长生存的养老院心梗后患者或代理人共同决策时,可告知他汀平均获益为1年延长生存约16天。
- 他汀对功能下降和再住院无总体影响,决策需结合患者偏好个体化。
局限性
- 回顾性队列设计,可能存在残余混杂。
- 研究数据为2007-2010年,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Studies examining the effects of statins after acute myocardial infarction (AMI) excluded frail older adults, especially nursing home (NH) residents, and few examined functional outcomes. Older NH residents may benefit less from statins and be particularly susceptible to adverse drug events like myopathy-related functional decline. We evaluated the effects of statins on 1-year functional decline, rehospitalization, and death in NH residents. DESIGN: We conducted a retrospective cohort study using 2007-2010 linked national data from Minimum Data Set (MDS) assessments, Medicare claims, and Online Survey Certification and Reporting System records. SETTING AND PARTICIPANTS: We included US NH residents 65 years and older who were statin nonusers, were hospitalized for AMI between May 2007 and March 2010, and returned to the NH. MEASURES: Outcomes were functional decline, death, and rehospitalization in the first year after post-AMI NH admission. New statin users were 1:1 propensity-score matched to nonusers to adjust for 92 characteristics. We estimated hazard ratios (HRs) and restricted mean survival time differences with 95% confidence intervals (CIs) comparing individuals who did vs did not initiate statin therapy after AMI hospitalization. RESULTS: Propensity-score matching yielded a cohort of 5440 residents. Mean age was 83 years and 69% were female. Statin use was associated with a reduction in mortality (HR 0.80, 95% CI 0.73-0.87), corresponding to a mean of 15.9 (95% CI 9.9-22.0) days of extended life expectancy. No overall differences in rehospitalization (HR 1.06, 95% CI 0.98-1.14) or functional decline (HR 1.00, 95% CI 0.88-1.14) were observed. CONCLUSIONS AND IMPLICATIONS: Statins may reduce 1-year mortality by 20% without affecting function among older NH residents who wish to live longer after AMI. During shared decision making with these patients or their representatives, clinicians should consider communicating that the average benefit of statins is 16 days of additional survival over 1 year.
引用
- Zullo AR, Ofori-Asenso R, Wood M, et al. Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents. J Am Med Dir Assoc. 2020. PMID: 32144051. doi:10.1016/j.jamda.2020.01.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。